Skip to main content
Clinical Trials/CTRI/2022/12/048343
CTRI/2022/12/048343
Not yet recruiting
Phase 3

Comparison of effects of dexmedetomidine-ketamine and midazolam-ketamine combination in transurethral procedures.

Sangey Doma Tamang0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Sponsor
Sangey Doma Tamang
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Sangey Doma Tamang

Eligibility Criteria

Inclusion Criteria

  • Patients of ASA physical status 1 and 2\. Patients able to comprehend and willing to participate. Patients scheduled for elective transurethral procedures.

Exclusion Criteria

  • Patientâ??s refusal to participate. Patients with known contraindication or sensitivity to study drugs. Patients on concomitant analgesic, sedative medication, or chronic use of an α\-agonist. Patients with chronic renal insufficiency, liver dysfunction, psychiatric or emotional disorders, respiratory disorders, sleep apnea, second or third degree heart block.

Outcomes

Primary Outcomes

Not specified

Similar Trials